These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 495276)

  • 41. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serum insulin during oral glucose tolerance].
    Frey H; Norman N
    Tidsskr Nor Laegeforen; 1971 Jun; 91(18):1392-7. PubMed ID: 5568060
    [No Abstract]   [Full Text] [Related]  

  • 43. Computer assisted analysis of insulin response to glucose stimulus.
    McReynolds CR; Shah S; Stoffer RP
    Ann Clin Lab Sci; 1973; 3(6):454-64. PubMed ID: 4585589
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and diabetes - a possible experimental model of maturity-onset-type diabetes.
    Inoue S; Iizuka T; Murao S
    Int J Obes; 1982; 6 Suppl 1():27-33. PubMed ID: 6214517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Glucose tolerance, insulin sensitivity, insulin activity of the blood and sinalbumin insulin antagonist in children and adolescents with diabetes mellitus heredity].
    Kniazev IuA; Smuliĭ LA; Shunaeva EN
    Pediatriia; 1973 Oct; 52(10):3-10. PubMed ID: 4783524
    [No Abstract]   [Full Text] [Related]  

  • 47. [Insulin secretion in maturity-onset diabetes mellitus. Effects of the prolonged administration of glybutamide].
    Duprey J; Lubetzki J
    Presse Med (1893); 1971 Dec; 79(54):2469-71. PubMed ID: 5157896
    [No Abstract]   [Full Text] [Related]  

  • 48. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree.
    Herman WH; Fajans SS; Ortiz FJ; Smith MJ; Sturis J; Bell GI; Polonsky KS; Halter JB
    Diabetes; 1994 Jan; 43(1):40-6. PubMed ID: 8262315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening.
    Jarrett RJ; Baker IA; Keen H; Oakley NW
    Br Med J; 1972 Jan; 1(5794):199-201. PubMed ID: 5058728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The insulin level in the glucose tolerance test in patients with obesity and varying carbohydrate tolerance (author's transl)].
    Graczykowska-Koczorowska A; Ponikowska I; Bruszyńska B; Tycowa M; Kosowicz J; Porawska J
    Przegl Lek; 1980; 37(2):301-4. PubMed ID: 6988899
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta cell dysfunction in maturity-onset diabetes: reversible loss of glucose-induced insulin secretion with retention of response to arginine.
    Savage PJ; Bennion LJ; Flock EV; Bennett PH
    Adv Exp Med Biol; 1979; 119():219-25. PubMed ID: 386726
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.
    Efendić S; Cerasi E; Elander I; Thornqvist C; Fick G; Berglund B; Luft R
    Acta Endocrinol Suppl (Copenh); 1979; 224():5-32. PubMed ID: 285561
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum insulin following isoprenaline in normal and diabetic persons.
    Deckert T; Lauridsen UB; Madsen SN; Deckert M
    Horm Metab Res; 1972 Jul; 4(4):229-32. PubMed ID: 5086194
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 55. [Insulin secretion after glucose loading. Studies on insulin secretion in healthy and diabetic subjects after administration of glucose].
    Haslbeck M
    Fortschr Med; 1974 Nov; 92(32):1317-8. PubMed ID: 4457437
    [No Abstract]   [Full Text] [Related]  

  • 56. On the pathogenesis of maturity-onset diabetes.
    Luft R; Wajngot A; Efendić S
    Diabetes Care; 1981; 4(1):58-63. PubMed ID: 7009116
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 58. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sugar diabetes. Update elements].
    De Flines J; Laurent A; Hennen G
    Rev Med Liege; 1998 Jul; 53(7):403-13. PubMed ID: 9926023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progression of early diabetes.
    Oppermann W; Velasco CA; Reddi AS; Hanover B; Camerini-Davalos RA
    Adv Exp Med Biol; 1979; 119():177-85. PubMed ID: 495277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.